On the other hand, the increase in TFH cells and plasma B cells suggests that T-B interaction leads to humoral immunity for ccRCC in TNFSF9-high-expression tumors (Figure 6). The gene discussed is TNFSF9; the disease is nonpapillary renal cell carcinoma.